Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Renovis

Explore full profile

Biopharmaceutical company developing drugs to treat neurological diseases and disorders

San Francisco, United StatesFounded 2000Biotech & Life Sciences
Valuation $100–250M Last recorded · 2007
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Renovis and the history behind them.

At a glance

Status
Acquired
Founded
2000
Headquarters
San Francisco, United States
Open positions
None listed
Dealroom signal
54.9/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Neurology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
b2b
Links
Website

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBTDebt Aug 2016 $3.5M — Undisclosed —
DEBTDebt Aug 2015 $1.4M — Undisclosed —
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

Renovis website traffic

Latest recorded traffic for Renovis is 0 monthly website visits.

Latest monthly visits0
Monthly website visitsOct 2017–May 2020
Explore monthly traffic historyTrack growth over time and compare with peersBook a demo
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Mitotype Precision LabsHigh-throughput mitochondrial assays for drug discovery Sheffield, United Kingdom Operational 8 $1.4M $3.3M
Draig TherapeuticsTargeted neuromodulators for major neuropsychiatric disorders treatment Cardiff, United Kingdom Operational
Cellestial HealthPioneering brain disease treatment by targeting astrocytic networks with sustainable pharmaceutical practices Cambridge, United Kingdom Operational
Neusignal TherapeuticsTherapeutic drugs for Central Nervous System diseases Tokyo, Japan Operational
Transcend TherapeuticsDeveloping the next generation of psychoactive compounds for neuropsychiatry focused on patient access New York City, United States Acquired
AviadoBioPrecision gene therapies for neurodegenerative disorders London, United Kingdom Operational
Teitur TrophicsCyclic peptide therapeutics for neurodegenerative diseases Aarhus, Denmark Operational
Eikonizo TherapeuticsDeveloping therapies to improve the treatment of human disease, specifically neurodegenerative diseases Cambridge, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A7 investors entered at this stage

Series B and later1 investor entered at this stage

  • Easton Capital Investment Group

Other known investors3 additional known investors

  • Evotec
  • University of California, Berkeley
  • HealthCap

Talent

Book a demo to see the people
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Francisco HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Renovis on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Renovis’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.